Andreas G Ladurner |
|
|
|
Ludwig-Maximilian-University of Munich
·
Chair of Physiological Chemistry
|
Research experience
-
Jan 2011–
Dec 2012Research: Ludwig-Maximilian-University of Munich
Ludwig-Maximilian-University of Munich · Faculty of MedicineGermany · München -
Jan 2008–
presentResearch: Deutsches Krebsforschungszentrum
Deutsches Krebsforschungszentrum · Division of Molecular Biology of the Cell IIGermany · Heidelberg -
Jan 2005–
Dec 2010Research: European Molecular Biology Laboratory
European Molecular Biology LaboratoryGermany · Heidelberg -
Jan 2003–
presentResearch: Howard Hughes Medical Institute
Howard Hughes Medical InstituteUSA · Chevy Chase -
Jan 2000–
presentResearch: University of California, Berkeley
University of California, Berkeley · Department of Molecular and Cell BiologyUSA · Berkeley -
Jan 1996–
presentResearch: University of Cambridge
University of Cambridge · Department of ChemistryUnited Kingdom · Cambridge
Publications (63) View all
-
Article: The chaperone-histone partnership: for the greater good of histone traffic and chromatin plasticity.
Maria Hondele, Andreas G Ladurner[show abstract] [hide abstract]
ABSTRACT: Histones are highly positively charged proteins that wrap our genome. Their surface properties also make them prone to nonspecific interactions and aggregation. A class of proteins known as histone chaperones is dedicated to safeguard histones by aiding their proper incorporation into nucleosomes. Histone chaperones facilitate ordered nucleosome assembly and disassembly reactions through the formation of semi-stable histone-chaperone intermediates without requiring ATP, but merely providing a complementary protein surface for histones to dynamically interact with. Recurrent 'chaperoning' mechanisms involve the masking of the histone's positive charge and the direct blocking of crucial histone surface sites, including those required for H3-H4 tetramerization or the binding of nucleosomal DNA. This shielding prevents histones from engaging in premature or unwanted interactions with nucleic acids and other cellular components. In this review, we analyze recent structural studies on chaperone-histone interactions and discuss the implications of this vital partnership for nucleosome assembly and disassembly pathways.Current Opinion in Structural Biology 11/2011; 21(6):698-708. · 9.42 Impact Factor -
Article: PARG: a macrodomain in disguise.
Markus Hassler, Gytis Jankevicius, Andreas G Ladurner[show abstract] [hide abstract]
ABSTRACT: Our understanding of poly-ADP-ribosylation as a posttranslational modification was limited by the lack of structural information on poly-ADP-ribose (PAR) hydrolysing enzymes. A recent study in Nature (Slade et al., 2011) reports the structure of PAR glycohydrolase (PARG), revealing unexpected similarity to the ubiquitous ADP-ribose-binding macrodomains.Structure 10/2011; 19(10):1351-3. · 6.35 Impact Factor -
SourceAvailable from: Stephanie Kueng
Article: Structural basis for the role of the Sir3 AAA+ domain in silencing: interaction with Sir4 and unmethylated histone H3K79.
Stefan Ehrentraut, Markus Hassler, Mariano Oppikofer, Stephanie Kueng, Jan M Weber, Jonathan W Mueller, Susan M Gasser, Andreas G Ladurner, Ann E Ehrenhofer-Murray[show abstract] [hide abstract]
ABSTRACT: The silent information regulator 2/3/4 (Sir2/3/4) complex is required for gene silencing at the silent mating-type loci and at telomeres in Saccharomyces cerevisiae. Sir3 is closely related to the origin recognition complex 1 subunit and consists of an N-terminal bromo-adjacent homology (BAH) domain and a C-terminal AAA(+) ATPase-like domain. Here, through a combination of structure biology and exhaustive mutagenesis, we identified unusual, silencing-specific features of the AAA(+) domain of Sir3. Structural analysis of the putative nucleotide-binding pocket in this domain reveals a shallow groove that would preclude nucleotide binding. Mutation of this site has little effect on Sir3 function in vivo. In contrast, several surface regions are shown to be necessary for the Sir3 silencing function. Interestingly, the Sir3 AAA(+) domain is shown here to bind chromatin in vitro in a manner sensitive to histone H3K79 methylation. Moreover, an exposed loop on the surface of this Sir3 domain is found to interact with Sir4. In summary, the unique folding of this conserved Sir3 AAA(+) domain generates novel surface regions that mediate Sir3-Sir4 and Sir3-nucleosome interactions, both being required for the proper assembly of heterochromatin in living cells.Genes & development 09/2011; 25(17):1835-46. · 12.08 Impact Factor -
Article: Histone macroH2A isoforms predict the risk of lung cancer recurrence.
[show abstract] [hide abstract]
ABSTRACT: Lung cancer is the leading cause of cancer deaths. Despite optimal diagnosis and early treatment, many patients die of recurrent disease. There are no sufficiently useful biomarkers to predict the risk of tumor recurrence. Here, we show that expression of histone macroH2A1.1 and macroH2A2 predicts lung cancer recurrence, identifying these histone variants as a novel tool for an improved risk stratification of cancer patients. Moreover, macroH2A isoforms are highly expressed in cells undergoing senescence, a known antitumor mechanism, suggesting macroH2A1.1 may be a useful biomarker for senescent cells in tumors.Oncogene 09/2009; 28(38):3423-8. · 6.37 Impact Factor -
SourceAvailable from: Andreas G Ladurner
Article: Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity.
[show abstract] [hide abstract]
ABSTRACT: Oxidative and hypertrophic stresses contribute to the pathogenesis of heart failure. Insulin-like growth factor-1 (IGF-1) is a peptide hormone with a complex post-transcriptional regulation, generating distinct isoforms. Locally acting IGF-1 isoform (mIGF-1) helps the heart to recover from toxic injury and from infarct. In the murine heart, moderate overexpression of the NAD(+)-dependent deacetylase SirT1 was reported to mitigate oxidative stress. SirT1 is known to promote lifespan extension and to protect from metabolic challenges. Circulating IGF-1 and SirT1 play antagonizing biological roles and share molecular targets in the heart, in turn affecting cardiomyocyte physiology. However, how different IGF-1 isoforms may impact SirT1 and affect cardiomyocyte function is unknown. Here we show that locally acting mIGF-1 increases SirT1 expression/activity, whereas circulating IGF-1 isoform does not affect it, in cultured HL-1 and neonatal cardiomyocytes. mIGF-1-induced SirT1 activity exerts protection against angiotensin II (Ang II)-triggered hypertrophy and against paraquat (PQ) and Ang II-induced oxidative stress. Conversely, circulating IGF-1 triggered itself oxidative stress and cardiomyocyte hypertrophy. Interestingly, potent cardio-protective genes (adiponectin, UCP-1 and MT-2) were increased specifically in mIGF-1-overexpressing cardiomyocytes, in a SirT1-dependent fashion. Thus, mIGF-1 protects cardiomyocytes from oxidative and hypertrophic stresses via SirT1 activity, and may represent a promising cardiac therapeutic.Aging 01/2009; 2(1):43-62. · 5.13 Impact Factor